NOV 21, 2016 2:44 PM PST

Urine Test Shows Promise in Detection of Cervical Cancer

WRITTEN BY: Xuan Pham
For women at high risk for cervical cancer, Hopkins researchers say they have a new diagnostic test that’s both non-invasive and more accurate than current tests on the market.
 
In profiling the genetic mutations that underlie cervical cancer, the research team identified a four-gene combination that can serve as biomarkers for the disease. Furthermore, they say the test can be done with urine samples, instead of using tissues collected from Pap tests.
 
Currently, routine Pap tests are recommended every 3 years for women between 21 and 65 years old. The test takes a swab of the cervical tissue to look for cancer cells. Women who have an abnormal Pap results and also test positive for the human papillomavirus (HPV) are then asked to undergo a biopsy to rule out cervical cancer. However, this method of screening is invasive, costly, and may not be necessary in at least 50 percent of cases.
 
Using hundreds of cervical cells collected, the Hopkins team built a diagnostic platform that consisted of a 4-gene panel. Three genes (FKBP6, INTS1 and ZNF516) were identified because they are highly associated with cervical cancer. The fourth gene (HPV16-L1) is an HPV gene that becomes methylated with cancer progression. With this four-gene panel, the team reported a sensitivity of 90.9 percent and a specificity of 60.9 percent.
 

"When developing a new cancer screening test, we want something in the range of 90 to 95 percent sensitivity, which is competitive with the effectiveness of tests developed and now marketed in Europe," said Rafael Guerrero-Preston, professor at the Johns Hopkins School of Medicine, and the study’s first author.
 
The new test is reported to surpass the sensitivity of two commercial tests, which have sensitivity of only 64 percent. In addition, because the tests rely on DNA methylation, Pap smears are required.
 
"If further studies confirm these findings, we see a significant use of urine screening as a way to quickly and inexpensively determine if a biopsy is warranted, or if physicians can use a 'watch and wait' approach before intervening," said Guerrero-Preston.
 
"Our urine test would serve as a molecular triage," he says, "at times supplementing Pap test information. In developing countries that don't have the money, medical infrastructure or cultural approval for Pap test, our test could be used instead."
 
Additional sources: Hopkins press release via News Wise
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 11, 2020
Clinical & Molecular DX
Smart Mask Detects COVID Infections, Sends Alert to Phone
NOV 11, 2020
Smart Mask Detects COVID Infections, Sends Alert to Phone
  This week, the Centers for Disease Control and Prevention issued new guidance to put the “mask debate&rdquo ...
NOV 30, 2020
Cancer
Developing Handheld Pulse Lasers to Destroy Cancer Tissue
NOV 30, 2020
Developing Handheld Pulse Lasers to Destroy Cancer Tissue
Many take modern surgeons and surgical methods for granted. In the grand scheme of things, it wasn’t too long ago ...
DEC 03, 2020
Neuroscience
Scientists Invent Noninvasive Microscope to Observe Neurons
DEC 03, 2020
Scientists Invent Noninvasive Microscope to Observe Neurons
To obtain high-resolution images of the brain, researchers usually need to reduce the thickness of the skull or cut into ...
DEC 10, 2020
Clinical & Molecular DX
Gut Feeling: Microbiome Reveals Toxic Chemical Exposure in Kids
DEC 10, 2020
Gut Feeling: Microbiome Reveals Toxic Chemical Exposure in Kids
A study by Duke University researchers has revealed that children’s gut microbiomes hold clues as to their possibl ...
DEC 15, 2020
Clinical & Molecular DX
Who Should Get the COVID Vaccine First?
DEC 15, 2020
Who Should Get the COVID Vaccine First?
Drug developers’ frantic hunt for vaccines against SARS-CoV-2 has finally begun to bear fruit, with several vaccin ...
DEC 30, 2020
Clinical & Molecular DX
Of Mice and Men: Deep Learning Transforms Diagnostics
DEC 30, 2020
Of Mice and Men: Deep Learning Transforms Diagnostics
Medical imaging technologies enable physicians to take a peek under the hood, capturing snapshots of the internal organs ...
Loading Comments...